Liposomes as nanomedical devices
Липосомы как устройства наномедицины
2015-02-01
SCID: 54.1/tza8kmum
Discuss with AI
drug-carrier systemsliposome physicochemical propertiesliposome-based drugsliposomesnanomedical devices
Figures from the paper
Abstract (AI)
Since their discovery in the 1960s, liposomes have been studied in depth, and they continue to constitute a field of intense research. Liposomes are valued for their biological and technological advantages, and are considered to be the most successful drug-carrier system known to date. Notable progress has been made, and several biomedical applications of liposomes are either in clinical trials, are about to be put on the market, or have already been approved for public use. In this review, we briefly analyze how the efficacy of liposomes depends on the nature of their components and their size, surface charge, and lipidic organization. Moreover, we discuss the influence of the physicochemical properties of liposomes on their interaction with cells, half-life, ability to enter tissues, and final fate in vivo. Finally, we describe some strategies developed to overcome limitations of the "first-generation" liposomes, and liposome-based drugs on the market and in clinical trials.
Key Findings
1
Liposome efficacy depends on component composition, particle size, surface charge, and lipid organization.
2
Liposome physicochemical properties determine cellular interactions, circulation half-life, tissue penetration, and in vivo fate.
3
Liposomes are regarded as the most successful drug-carrier system, with applications approved, in clinical trials, or approaching market introduction.
4
Liposomes have demonstrated broad biomedical potential, although their clinical behavior requires optimization of formulation properties.
5
Strategies have been developed to overcome limitations of first-generation liposomes and improve their biomedical performance.
Research Object
Liposomes as nanomedical drug-carrier systems
Research Subject
The dependence of liposome efficacy, cellular interactions, in vivo fate, and biomedical performance on composition, size, surface charge, lipid organization, and physicochemical properties
Publication Details
Publication Date
2015-02-01
Journal
Publisher
ISSN
Cited by
2275
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by9
Nano based drug delivery systems: recent developments and future prospects2018
Therapeutic Nanoparticles and Their Targeted Delivery Applications2020
Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine2019
Nanoemulsion and Nanoliposome Based Strategies for Improving Anthocyanin Stability and Bioavailability2019
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery2016
Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment2022
Liposome and Their Applications in Cancer Therapy2016
Artificial Intelligence-Assisted Design of Nanomedicines for Breast Cancer Diagnosis and Therapy: Advances, Challenges, and Future Directions2025
Opportunities for nanomaterials in enzyme therapy2024